{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:22:36Z","timestamp":1773692556369,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","award":["This research was performed within the framework of the Italian ClinicalService, a project funded by Medtronic Italy, an affiliate of Medtronic Inc"],"award-info":[{"award-number":["This research was performed within the framework of the Italian ClinicalService, a project funded by Medtronic Italy, an affiliate of Medtronic Inc"]}],"id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10840-018-0500-6","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:31:57Z","timestamp":1546475517000},"page":"267-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cryoballoon ablation of atrial fibrillation is effectively feasible without previous imaging of pulmonary vein anatomy: insights from the 1STOP project"],"prefix":"10.1007","volume":"55","author":[{"given":"A.","family":"Sagone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Iacopino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pieragnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Arena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Verlato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Molon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rovaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Curnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Rauhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lunati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Senatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Landolina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Allocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"De Servi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"issue":"9","key":"500_CR1","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","volume":"114","author":"J Andrade","year":"2014","unstructured":"Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453\u201368.","journal-title":"Circ Res"},{"key":"500_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983\u20138.","journal-title":"Stroke"},{"key":"500_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119\u201325.","journal-title":"Circulation"},{"issue":"11","key":"500_CR4","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609\u201378.","journal-title":"Europace"},{"key":"500_CR5","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. HRS\/EHRA\/ECAS\/ APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275\u2013444. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2017.05.012\n                    \n                  .","journal-title":"Heart Rhythm"},{"issue":"2","key":"500_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/pace.12787","volume":"39","author":"X He","year":"2016","unstructured":"He X, Chen Y, Zhou Y, Huang Y, He J. One-year clinical outcome of pulmonary vein isolation using the second-generation Cryoballoon: a meta-analysis. Pacing Clin Electrophysiol. 2016;39(2):182\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"key":"500_CR7","doi-asserted-by":"publisher","unstructured":"Arbelo E, Brugada J, Lundqvist CB, Laroche C, Kautzner J, Pokushalov E, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw564\n                    \n                  .","DOI":"10.1093\/eurheartj\/ehw564"},{"issue":"23","key":"500_CR8","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","volume":"374","author":"K-H Kuck","year":"2016","unstructured":"Kuck K-H, Brugada J, F\u00fcrnkranz A, Metzne A, Ouyang F, Julian Chun KR, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235\u201345. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1602014\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"5","key":"500_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/europace\/euv060","volume":"17","author":"F Squara","year":"2015","unstructured":"Squara F, Zhao A, Marijon E, Latcu DG, Providencia R, Di Giovanni G, et al. Comparison between radiofrequency with contact force-sensing and second-generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: a multicentre European evaluation. Europace. 2015;17(5):718\u201324.","journal-title":"Europace"},{"issue":"2","key":"500_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00330-016-4411-6","volume":"27","author":"J Chen","year":"2017","unstructured":"Chen J, Yang ZG, Xu HY, Shi K, Long QH, Guo YK. Assessments of pulmonary vein and left atrial anatomical variants in atrial fibrillation patients for catheter ablation with cardiac CT. Eur Radiol. 2017;27(2):660\u201370. \n                    https:\/\/doi.org\/10.1007\/s00330-016-4411-6\n                    \n                  .","journal-title":"Eur Radiol"},{"key":"500_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/ehjci\/jex312","volume":"19","author":"S Liddy","year":"2017","unstructured":"Liddy S, Buckley U, Kok HK, Loo B, Glover B, Dhillon GR, et al. Applications of cardiac computed tomography in electrophysiology intervention. Eur Heart J Cardiovasc Imaging. 2017;19:253\u201361. \n                    https:\/\/doi.org\/10.1093\/ehjci\/jex312\n                    \n                  .","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"500_CR12","doi-asserted-by":"publisher","first-page":"407.e1","DOI":"10.1016\/j.jcct.2010.11.001","volume":"4","author":"AJ Taylor","year":"2010","unstructured":"Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O'Gara P, et al. ACCF\/SCCT\/ACR\/AHA\/ASE\/ASNC\/NASCI \/SCAI\/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the north American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Comput Tomogr. 2010;4(6):407.e1\u201333. \n                    https:\/\/doi.org\/10.1016\/j.jcct.2010.11.001\n                    \n                  .","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"1","key":"500_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/pace.12975","volume":"40","author":"L Padeletti","year":"2017","unstructured":"Padeletti L, Curnis A, Tondo C, Lunati M, Porcellini S, Verlato R, et al. Pulmonary vein isolation with the cryoballoon technique: feasibility, procedural outcomes, and adoption in the real world: data from one shot technologies to pulmonary vein isolation (1STOP) project. Pacing Clin Electrophysiol. 2017;40(1):46\u201356.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"500_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.hrthm.2017.10.038","volume":"15","author":"C Tondo","year":"2018","unstructured":"Tondo C, Iacopino S, Pieragnoli P, Molon G, Verlato R, Curnis A, et al. ClinicalService 1STOP project investigators. Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: clinical outcomes from the real-world multicenter observational project. Heart Rhythm. 2018;15(3):363\u20138.","journal-title":"Heart Rhythm"},{"key":"500_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2018.07.051","volume":"272","author":"M Landolina","year":"2018","unstructured":"Landolina M, Arena G, Iacopino S, Verlato R, Pieragnoli P, Curnis A, et al. Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: data on 860 patients from the real-world multicenter observational project. Int J Cardiol. 2018;272:130\u20136.","journal-title":"Int J Cardiol"},{"issue":"2","key":"500_CR16","first-page":"241","volume":"19","author":"E Yang","year":"2017","unstructured":"Yang E, Ipek EG, Balouch M, Mints Y, Chrispin J, Marine JE, et al. Factors impacting complication rates for catheter ablation of atrial fibrillation from 2003 to 2015. Europace. 2017;19(2):241\u20139.","journal-title":"Europace"},{"key":"500_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1540-8167.2004.03515.x","volume":"15","author":"M Mansur","year":"2004","unstructured":"Mansur M, Holmvang G, Sosnovik D, Migrino R, Abbara S, Ruskin J, et al. Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15:387\u201393.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"500_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10840-016-0106-9","volume":"46","author":"FM Merchant","year":"2016","unstructured":"Merchant FM, LevY MR, Iravanian S, Clermont EC, Kelli HM, Eisner RL, et al. Pulmonary vein anatomy assessed by cardiac magnetic resonance imaging in patients undergoing initial atrial fibrillation ablation: implications for novel ablation technologies. J Interv Card Electrophysiol. 2016;46:89\u201396.","journal-title":"J Interv Card Electrophysiol"},{"issue":"10","key":"500_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4330\/wjc.v9.i10.773","volume":"9","author":"E Maria De","year":"2017","unstructured":"De Maria E, Aldrovandi A, Borghi A, Modonesi L, Cappelli S. Cardiac magnetic resonance imaging: which information is useful for the arrhythmologist? World J Cardiol. 2017;9(10):773\u201386.","journal-title":"World J Cardiol"},{"key":"500_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCEP.113.000899","volume":"7","author":"F Straube","year":"2014","unstructured":"Straube F, Dorwarth U, Schmidt M, Wankerl M, Ebersberger U, Hoffmann E. Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol. 2014;7:293\u20139.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"500_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","volume":"3","author":"R Cappato","year":"2010","unstructured":"Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"500_CR22","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.hrthm.2011.03.050","volume":"8","author":"JG Andrade","year":"2011","unstructured":"Andrade JG, Khairy P, Guerra PG, Deyell MW, Rivard L, Macle L, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: systematic a systematic review of published studies. Heart Rhythm. 2011;8:1444\u201351.","journal-title":"Heart Rhythm"},{"issue":"23","key":"500_CR23","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.jacc.2011.08.045","volume":"58","author":"TF Chao","year":"2011","unstructured":"Chao TF, Lin YJ, Tsao HM, Tsai CF, Lin WS, Chang SL, et al. CHADS2 and CHA2DS2-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol. 2011;58(23):2380\u20135. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.08.045\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"500_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cjca.2014.01.005","volume":"30","author":"TF Chao","year":"2014","unstructured":"Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, et al. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score. Can J Cardiol. 2014;30(4):405\u201312.","journal-title":"Can J Cardiol"},{"issue":"2","key":"500_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/europace\/eut210","volume":"16","author":"KP Letsas","year":"2014","unstructured":"Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, et al. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2014;16(2):202\u20137. \n                    https:\/\/doi.org\/10.1093\/europace\/eut210\n                    \n                  .","journal-title":"Europace"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0500-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-018-0500-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0500-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:36:54Z","timestamp":1577993814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-018-0500-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1007\/s10840-018-0500-6","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"1 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this project involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Maurizio Lunati and Roberto Verlato received modest consultancy and speaker\u2019s fees from Medtronic. Maurizio Landolina received modest consultancy and speaker\u2019s fees from Medtronic, Boston Scientific, and Boehringer Ingelheim. Giulio Molon received modest consultancy fees from Medtronic and Boston Scientific and speaker\u2019s fees from Medtronic, Boston Scientific, St. Jude, and Boehringer Ingelheim. Claudio Tondo serves as a member of Medtronic European Advisory Board and Boston Scientific International Advisory Board. He received lecture and proctor fees from Medtronic, Abbott Medical, Biosense Webster, and Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest disclosures"}},{"value":"This project was approved by each site\u2019s Institutional Review Board and Local Ethics Committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Each patient included in the ClinicalService project provided informed consent for data collection and analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}